An autopsy case of G
GM1 gangliosidosis
artificial respiratory support
autopsy
late infantile
long duration
Journal
Neuropathology : official journal of the Japanese Society of Neuropathology
ISSN: 1440-1789
Titre abrégé: Neuropathology
Pays: Australia
ID NLM: 9606526
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
06
02
2020
revised:
11
02
2020
accepted:
12
02
2020
pubmed:
29
3
2020
medline:
28
8
2021
entrez:
29
3
2020
Statut:
ppublish
Résumé
G
Substances chimiques
GLB1 protein, human
EC 3.2.1.23
beta-Galactosidase
EC 3.2.1.23
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
379-388Informations de copyright
© 2020 Japanese Society of Neuropathology.
Références
Suzuki Y, Nanba E. β-Galactosidase deficiency (β-galactosidosis): GM1 gangliosidosis and Morquio B disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, (eds). The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2001; 3775-3809.
Morrone A, Bardelli T, Donati MA et al. β-galactosidase gene mutations affecting the lysosomal enzyme and the elastin-binding protein in GM1-gangliosidosis patients with cardiac involvement. Hum Mutat 2000; 15: 354-366.
Caciotti A, Garman SC, Rivera-Colon Y et al. GM1 gangliosidosis and Morquio B disease: An update on genetic alterations and clinical findings. Biochim Biophys Acta 1812; 2011: 782-790.
Suzuki K, Chen GC. Morphological, histochemical and biochemical studies on a case of systemic late infantile lipidosis (generalized gangliosidosis). J Neuropathol Exp Neurol 1968; 27: 15-38.
O'Brien JS, Ho MW, Veath ML et al. Juvenile GM1 gangliosidosis: Clinical, pathological, chemical and enzymatic studies. Clin Genet 1972; 3: 411-434.
Gilbert EF, Varakis J, Opitz JM et al. Generalized gangliosidosis type II (juvenile GM1 gangliosidosis). A pathological, histochemical and ultrastructural study. Z Kinderheilkd 1975; 120: 151-180.
Folkerth RD, Alroy J, Bhan I, Kaye EM. Infantile G(M1) gangliosidosis: Complete morphology and histochemistry of two autopsy cases, with particular reference to delayed central nervous system myelination. Pediatr Dev Pathol 2000; 3: 73-86.
van der Voorn JP, Kamphorst W, van der Knaap MS, Powers JM. The leukoencephalopathy of infantile GM1 gangliosidosis: Oligodendrocytic loss and axonal dysfunction. Acta Neuropathol 2004; 107: 539-545.
Kuki I, Tomiwa K, Okazaki S, Ikeda H, Kawawaki H. Late infantile GM1 gangliosidosis with progressive dilatation of common bile duct and obstructive apnea-an autopsy case (In Japanese with English abstract.). Brain Dev 2007; 39: 54-58.
Hachiya Y, Hayashi M. An 11-year-old boy showing rapid psychomotor regression and diffuse cerebral white matter lesions. Neuropathology 2009; 29: 517-519.
Nada R, Gupta K, Lal SB, Vasishta RK. An autopsy case of infantile GM1 gangliosidosis with adrenal calcification. Metab Brain Dis 2011; 26: 307-310.
Goldman JE, Katz D, Rapin I, Purpura DP, Suzuki K. Chronic GM1 gangliosidosis presenting as dystonia: I. Clinical and pathological features. Ann Neurol 1981; 9: 465-475.
Suzuki K. Neuropathology of late onset gangliosidoses. A review. Dev Neurosci 1991; 13: 205-210.
Yoshida K, Oshima A, Shimmoto M et al. Human beta-galactosidase gene mutations in GM1-gangliosidosis: A common mutation among Japanese adult/chronic cases. Am J Hum Genet 1991; 49: 435-442.
Richards S, Aziz N, Bale S et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-424.
Feng Y, Huang Y, Zhao X et al. Clinical and molecular characteristics of 11 Chinese probands with GM1 gangliosidosis. Metab Brain Dis 2018; 33: 2051-2057.
Yoshida K, Ikeda S, Kawaguchi K, Yanagisawa N. Adult GM1 gangliosidosis: Immunohistochemical and ultrastructural findings in an autopsy case. Neurology 1994; 44: 2376-2382.
Lee JS, Choi JM, Lee M et al. Diagnostic challenge for the rare lysosomal storage disease: Late infantile GM1 gangliosidosis. Brain Dev 2018; 40: 383-390.
Matsuda J, Suzuki O, Oshima A et al. Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis. Proc Natl Acad Sci U S A 2003; 100: 15912-15917.